Chronotherapy with the Glucokinase Activator AZD1656 Greatly Affects Its Ability to Improve Metabolism in Obese Zucker Rats

AZD1656 - AstraZeneca

https://eppro02.ativ.me/web/page.php?page=IntHtml&project=ADA22&id=1050

TOBIAS KROON; THERESE HAGSTEDT; IDA ALEXANDERSSON; ANNETT FERM; MARIE PETERSSON; STEFANIE MAURER; BADER ZARROUKI; KRISTINA WALLENIUS; NICHOLAS D. OAKES; JEREMIE BOUCHER

May 11, 2022